Matthew Halpert

Matthew Halpert, PhD

President

Dr. Matthew Halpert earned his doctorate at the University of Alabama-Birmingham (UAB), and then spent 10 years at Baylor College of Medicine in Houston as a Cancer Immunologist. During his research, Dr. Halpert published research in some of the most prestigious peer reviewed journals, has been cited over 300 hundred times, and became one of the leading experts in regard to cutting-edge cancer immunotherapy.

Additionally, he has founded Diakonos Research, which is currently studying its revolutionary Dendritic Cell Treatment in multiple FDA clinical trials.

In 2021, Dr. Halpert left Baylor College of Medicine to found the Immunocine Cancer Center, which leverages the Dendritic Cell Treatment currently being studied by the FDA.

Education

PhD in Microbiology and Immunology, University of Alabama at Birmingham

BS in Biology, Southwestern University